Panel Affirms 3 Patents Infringed, But Says 2 Others Not

Mealey's (March 26, 2020, 11:29 AM EDT) -- WASHINGTON, D.C. — Citing a lack of “particularized testimony,” the Federal Circuit U.S. Court of Appeals on March 25 reversed findings by a Delaware federal judge that two patents are infringed under the doctrine of equivalents by a proposed treatment of low-dose doxycycline for acne or rosacea (Galderma Laboratories L.P., et al. v. Amneal Pharmaceuticals LLC, et al., No. 19-1021, Fed. Cir., 2020 U.S. App. LEXIS 9341)....